IOSP stock holds near 52-week levels as investors wait
Published on 08/29/2026 at 21:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Innospec Inc. (US45768S1033) stock is holding a market value of $2.09 billion as of August 28, 2026, while the latest figures tied to the business still point to a company with $3.67 billion in revenue, $268.1 million in net income and $6.10 in diluted EPS for the most recent full-year comparison set visible in market data.
The share setup matters because the stock has also been quoted at $93.37, with a 1.44 percent daily decline shown in one late-August market snapshot, and that leaves investors balancing a sub-$100 price with a market cap that still sits above $2 billion.
Market level to watch
The most useful comparison is the spread between that $93.37 quote and the $2.09 billion market cap, which shows how tightly the current valuation is tied to each move in the stock. A move of 1.44 percent on the session is modest in absolute terms, but it still changes the equity value of a mid-cap name like IOSP by tens of millions of dollars.
For a stock trading in this range, the message from the quote data is simple: investors are still paying close attention to every incremental move in the price, because the valuation backdrop is not stretched enough to ignore and not cheap enough to dismiss.
Fundamentals still matter
The latest reported full-year numbers visible in the available data show $3.67 billion of revenue, $268.1 million of net income and $6.10 of diluted EPS. That combination gives IOSP a profit profile that is still meaningful relative to its size, and it is the kind of base that helps explain why the stock can hold a premium to smaller specialty chemical peers.
Historically, the comparison is even clearer: the same market data set shows the company at a $2.09 billion market capitalization, so the equity is valued at a little more than seven times that annual net income figure. That is a concrete ratio investors can use when deciding whether the current share price looks demanding or restrained.
Product lens
Innospec's portfolio spans specialty chemicals used in fuels, performance chemicals and personal care applications, which means the company does not depend on a single end market for every dollar of revenue. That mix can soften swings when one segment slows, while also making margin discipline a central part of the investment case.
The product side matters because the company's reported earnings power is tied to more than just volume growth; mix, pricing and cost control all feed into the final numbers. For shareholders, that makes the next set of reported figures more relevant than any broad sector label.
Closing view
With IOSP quoted at $93.37 and carrying a $2.09 billion market cap, the stock is priced as a mid-cap specialty chemicals name rather than a high-growth rerating story. The valuation question now rests on whether the revenue base near $3.67 billion and the $6.10 EPS profile can keep supporting that market value.
Company details
Company: Innospec Inc.
ISIN: US45768S1033
Ticker: IOSP
Exchange: Nasdaq
Market cap: $2.09 billion (as of August 28, 2026)
Sector / Industry: Materials / Specialty Chemicals
More on IOSP stock
Innospec Inc. sells specialty chemicals across fuels, personal care and performance products.
